泰K
泰福-KY Stock: price and insider trades · Taiwan
泰福-KY: what insiders have been doing
Insider filings for 泰福-KY are scarce in the TWSE / TPEx (MOPS) feed, the latest one published on 23 October 2017. This page will fill in as new trades are disclosed. Source: insider filings from TWSE / TPEx (MOPS). Past trades are no guide to future returns.
Insider Decl.
7
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended December 2025 · cache
NT$30
Analyst consensus
Income statement
RevenueNT$401M
Gross profit-NT$440.7M-110% margin
EBITDA-NT$1.1B-272% margin
Net income-NT$1.5B-222.8% margin
Valuation
P/Book1.6x
Beta0.20
Balance sheet & cash
Market capNT$7.9B
Total debtNT$1.6B
Free Cash Flow-NT$1.7B
Debt / Equity42%
Profitability & ownership
ROE-29.8%
ROA-12.3%
% insiders60.8%
% institutions0.1%
Last declaration on 23 October 2017
Declarations7 total
- 125,000 sharesShareTWSETWMOPS:6541:106/10/23:tanvexbiologicsinc:11o4f24
- 250,000 sharesShareTWSETWMOPS:6541:106/10/23:鵬霖投資有限公司:0vqogyv
- 125,000 sharesShareTWSETWMOPS:6541:106/10/23:allenchaoandleehwachaofa:0f2cozf
- 390,000 sharesShareTWSETWMOPS:6541:104/08/11:tanvexbiologicsinc:0rqbgbp
- 740,000 sharesShareTWSETWMOPS:6541:104/08/11:鵬霖投資有限公司:0k3l4hb
- 40,000 sharesShareTWSETWMOPS:6541:104/08/10:鵬霖投資有限公司:1k48svv
- 40,000 sharesShareTWSETWMOPS:6541:104/08/07:鵬霖投資有限公司:0kevhng
7 of 7 declarations
About 泰福-KY
Tai Fu-KY is a company listed on the XTAI market, specializing in the financial sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
